Orally Dissolving Technology Excipient

Abstract This research implements a computer-aided formulation development algorithm based on a novel SeDeM-ODT expert system in establishing the design...

Abstract The antiparasitic drug ivermectin is approved for persons > 15 kg in the US and EU. A pharmacometric (PMX)...

This poster was presented at EuPFI 2024 in Rotterdam. Introduction Loratadine, an antihistamine medication, is widely prescribed for the treatment...

The oral bioavailability of sildenafil citrate is approximately 43%, primarily limited by the low aqueous solubility and first-pass effect. Considering...

New co-processed excipients comprising lactose (filler and sweetener), microcrystalline cellulose (MCC, filler), and low-substituted hydroxypropyl cellulose (L-HPC, disintegrant and binder)...

Abstract In recent years, solid dosage forms have gained interest in pediatric therapy because they can provide valuable benefits in...

Abstract Ivermectin has been used since the 1980s as an anthelmintic and antiectoparasite agent worldwide. Currently, the only available oral...

In this paper, the inclusion complexes (ICs) of hydroxypropyl-beta-cyclodextrin (HPβCD) and risperidone were electrospun into nanofibrous film for potential fast-disintegrating...

Struggling with complex multi-excipient formulations for Orally Disintegrating Tablets (ODTs)? Look no further than HiCel HFS! This coprocessed excipient combines...

The targeting and mucoadhesive features of chitosan (CS)-linked solid lipid nanoparticles (SLNs) were exploited to efficiently deliver fexofenadine (FEX) into...